WVU Medicine transforming asthma and COPD care through new comprehensive clinic

MORGANTOWN, W.Va. – A task that is easy and effortless to perform is often described as “as natural as breathing.” For the estimated half billion people worldwide living with chronic obstructive lung diseases, breathing difficulty can affect not just their health, but quality of life.

The newly launched Comprehensive Obstructive Lung Disease and Asthma Program at WVU Medicine J.W. Ruby Memorial Hospital aims to improve care for patients living with asthma and chronic obstructive pulmonary disease (COPD). 

As the burden of chronic respiratory diseases continues to rise, the Program introduces a proactive, coordinated approach designed to enhance patient outcomes, expand access to advanced therapies, and reduce strain on the healthcare system. 

Developed by the WVU Medicine Division of Pulmonary, Critical Care, and Sleep Medicine, the Program integrates clinical care, education, and research to better address the complexities of obstructive lung disease. This dedicated structure for asthma and COPD management strengthens care delivery while supporting the training of future clinicians and advancing research in respiratory health. 

A key component of the Program is the use of point-of-care diagnostic tools, including exhaled nitric oxide testing and in-clinic spirometry. These technologies allow providers to assess airway inflammation and lung function in real time, enabling faster, data-driven decisions and more personalized treatment plans during patient visits. 

“By introducing this concept, we have flipped the script from being reactive to proactive in our practice of medicine,” Sunil Sharma, M.D., chief of Pulmonary, Critical Care, and Sleep Medicine, said. “This approach allows us to connect with patients more frequently, intervene earlier, and ultimately prevent disease progression. The WVU Medicine Comprehensive Obstructive Lung Disease and Asthma Program is also home to multiple clinical trials, providing patients with opportunities to access cutting-edge therapies for COPD, asthma, and bronchiectasis."

The Program also offers advanced biologic therapies for patients with severe or difficult-to-control asthma and COPD. Led by Srinivasa Potla, M.D., the initiative helps ensure eligible patients are identified early and treated using the latest evidence-based approaches.  

"Severe and difficult-to-control asthma and COPD place a major burden on patients, families, and the healthcare system across West Virginia. To combat this, we created an Advanced Obstructive Lung Disease Clinic to bring specialized, coordinated care to patients. This will allow earlier detection of high-risk patients, improve access to advanced therapies such as biologics, and strengthen follow-ups,” Dr. Potla said.  

“Our goal is simple: help people breathe easier, stay out of the hospital, and live fuller, more active lives through personalized treatment, advanced therapies, and a dedicated team." 

Patient navigators play a central role in the Program’s care model, helping coordinate services, facilitate access to therapy, and ensure consistent follow-up. This added layer of support strengthens communication and improves patient engagement throughout the care journey. 

To further expand access, the Program incorporates telemedicine services to reach patients in rural and underserved areas of the state. By reducing geographic barriers, telehealth enables more timely care and improves continuity for patients who may otherwise face challenges traveling to specialty appointments. 

To learn more about WVU Medicine, visit WVUMedicine.org.